Brian Abrahams
Stock Analyst at RBC Capital
(2.26)
# 2,764
Out of 5,055 analysts
443
Total ratings
45.38%
Success rate
-5.08%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Maintains: Outperform | $19 → $18 | $10.30 | +74.76% | 5 | Nov 14, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Outperform | $55 → $53 | $11.13 | +376.40% | 9 | Nov 13, 2025 | |
| ATYR aTyr Pharma | Maintains: Sector Perform | $1.5 → $1 | $0.71 | +39.98% | 2 | Nov 7, 2025 | |
| PRTA Prothena Corporation | Maintains: Sector Perform | $10 → $11 | $10.22 | +7.63% | 12 | Nov 7, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Sector Perform | $3 → $2 | $1.72 | +16.62% | 14 | Nov 7, 2025 | |
| MNMD Mind Medicine (MindMed) | Maintains: Outperform | $21 → $20 | $11.19 | +78.73% | 10 | Nov 7, 2025 | |
| GLPG Galapagos NV | Maintains: Sector Perform | $28 → $32 | $31.61 | +1.25% | 13 | Nov 7, 2025 | |
| CDTX Cidara Therapeutics | Maintains: Outperform | $137 → $145 | $217.75 | -33.41% | 2 | Nov 7, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Outperform | $34 → $32 | $23.54 | +35.94% | 3 | Nov 6, 2025 | |
| PTCT PTC Therapeutics | Maintains: Outperform | $70 → $82 | $74.95 | +9.41% | 22 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $58 | $40.13 | +44.53% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $423 → $415 | $435.93 | -4.80% | 56 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $19 | $5.57 | +241.42% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $70 | $65.10 | +7.54% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $105 | $123.24 | -14.80% | 33 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $217 → $210 | $166.87 | +25.85% | 41 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $704 → $708 | $691.50 | +2.39% | 34 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $156 → $160 | $144.27 | +10.91% | 23 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $81 → $84 | $104.30 | -19.46% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $67 → $10 | $12.61 | -20.70% | 3 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $70 | $66.63 | +5.06% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Perform | $22 | $36.50 | -39.73% | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $23 | $18.07 | +27.28% | 35 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $13 | $6.96 | +86.92% | 19 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $31 | $10.82 | +186.64% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $1.5 | $0.25 | +495.00% | 6 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $30.77 | +172.99% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $14.12 | +119.55% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $2.73 | +46.52% | 6 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $138.27 | +3.42% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $38.34 | +4.33% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $12.28 | +22.15% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $4.02 | +123.88% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $33 | $96.19 | -65.69% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.80 | - | 4 | Dec 4, 2017 |
Aardvark Therapeutics
Nov 14, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $10.30
Upside: +74.76%
Corbus Pharmaceuticals Holdings
Nov 13, 2025
Maintains: Outperform
Price Target: $55 → $53
Current: $11.13
Upside: +376.40%
aTyr Pharma
Nov 7, 2025
Maintains: Sector Perform
Price Target: $1.5 → $1
Current: $0.71
Upside: +39.98%
Prothena Corporation
Nov 7, 2025
Maintains: Sector Perform
Price Target: $10 → $11
Current: $10.22
Upside: +7.63%
Pliant Therapeutics
Nov 7, 2025
Maintains: Sector Perform
Price Target: $3 → $2
Current: $1.72
Upside: +16.62%
Mind Medicine (MindMed)
Nov 7, 2025
Maintains: Outperform
Price Target: $21 → $20
Current: $11.19
Upside: +78.73%
Galapagos NV
Nov 7, 2025
Maintains: Sector Perform
Price Target: $28 → $32
Current: $31.61
Upside: +1.25%
Cidara Therapeutics
Nov 7, 2025
Maintains: Outperform
Price Target: $137 → $145
Current: $217.75
Upside: -33.41%
ACADIA Pharmaceuticals
Nov 6, 2025
Maintains: Outperform
Price Target: $34 → $32
Current: $23.54
Upside: +35.94%
PTC Therapeutics
Nov 5, 2025
Maintains: Outperform
Price Target: $70 → $82
Current: $74.95
Upside: +9.41%
Nov 4, 2025
Maintains: Outperform
Price Target: $55 → $58
Current: $40.13
Upside: +44.53%
Nov 4, 2025
Maintains: Sector Perform
Price Target: $423 → $415
Current: $435.93
Upside: -4.80%
Nov 4, 2025
Maintains: Outperform
Price Target: $30 → $19
Current: $5.57
Upside: +241.42%
Nov 3, 2025
Maintains: Outperform
Price Target: $60 → $70
Current: $65.10
Upside: +7.54%
Oct 31, 2025
Maintains: Sector Perform
Price Target: $100 → $105
Current: $123.24
Upside: -14.80%
Oct 31, 2025
Maintains: Outperform
Price Target: $217 → $210
Current: $166.87
Upside: +25.85%
Oct 29, 2025
Maintains: Sector Perform
Price Target: $704 → $708
Current: $691.50
Upside: +2.39%
Oct 29, 2025
Maintains: Outperform
Price Target: $156 → $160
Current: $144.27
Upside: +10.91%
Oct 29, 2025
Maintains: Sector Perform
Price Target: $81 → $84
Current: $104.30
Upside: -19.46%
Sep 29, 2025
Downgrades: Sector Perform
Price Target: $67 → $10
Current: $12.61
Upside: -20.70%
Sep 16, 2025
Initiates: Outperform
Price Target: $70
Current: $66.63
Upside: +5.06%
Sep 3, 2025
Initiates: Sector Perform
Price Target: $22
Current: $36.50
Upside: -39.73%
Jul 17, 2025
Maintains: Sector Perform
Price Target: $25 → $23
Current: $18.07
Upside: +27.28%
Jun 30, 2025
Reiterates: Outperform
Price Target: $13
Current: $6.96
Upside: +86.92%
May 15, 2025
Reiterates: Outperform
Price Target: $31
Current: $10.82
Upside: +186.64%
May 14, 2025
Reiterates: Sector Perform
Price Target: $1.5
Current: $0.25
Upside: +495.00%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $30.77
Upside: +172.99%
Mar 7, 2025
Initiates: Outperform
Price Target: $31
Current: $14.12
Upside: +119.55%
Mar 4, 2025
Reiterates: Sector Perform
Price Target: $4
Current: $2.73
Upside: +46.52%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $138.27
Upside: +3.42%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $38.34
Upside: +4.33%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $12.28
Upside: +22.15%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $4.02
Upside: +123.88%
Nov 3, 2021
Maintains: Sector Perform
Price Target: $21 → $33
Current: $96.19
Upside: -65.69%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $32.80
Upside: -